T cells that self-supercharge can kill pancreatic cancer, according to research

In a new study published in the journal Science, researchers have found that T cells that have been genetically modified to self-supercharge can kill pancreatic cancer cells.

This is a major breakthrough in the fight against pancreatic cancer, which is one of the most aggressive and difficult-to-treat forms of cancer.

The study was conducted by a team of researchers at the University of Pennsylvania.

They took T cells from patients with pancreatic cancer and modified them so that they would express a protein called CAR-T.

This protein allows the T cells to recognize and attack cancer cells.

The modified T cells were then injected into the patients’ tumors.

The results were amazing.

The T cells were able to kill the cancer cells and shrink the tumors.

What’s even more incredible is that the T cells continued to kill cancer cells even when they were no longer injected with the CAR-T protein.

This shows that the T cells had become “self-sufficient” and were able to keep attacking the cancer cells on their own.

The researchers believe that this approach could be used to treat other types of cancer, and they are already working on clinical trials

Group Media Publications
General News Platform – https://ihtlive.com/
Entertainment News Platforms – anyflix.in 
Construction Infrastructure and Mining News Platform – https://cimreviews.com/
Podcast Platforms – https://anyfm.in/